Lipid blood biomarkers mediating olfaction with cognitive and mobility impairment

Abstract

Background: Olfactory deficit is consistently associated with age‐related cognitive and mobility decline, and one of the earliest signs of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. However, the underlying mechanisms are not fully understood.